WHITEHAWK THERAPEUTICS INC (f.k.a AADI BIOSCIENCES INC) 00032Q104 US00032Q1040 BBG002WN7DT2 6/11/2026 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the “Executive Compensation” section of the proxy statement. SECTION 14A SAY-ON-PAY VOTES To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof ISSUER 0 0 ABSTAIN 0 NONE PERSPECTIVE THERAPEUTICS INC 46489V302 US46489V3024 BBG000BG5HT7 5/27/2026 To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES To conduct any other business properly brought before the Annual Meeting ISSUER 0 0 ABSTAIN 0 NONE